Today : Mar 01, 2025
Business
01 March 2025

Mega-Cap Stocks Show Mixed Performance Against Market Indices

Recent trading sessions reveal Broadcom, Coca-Cola, Eli Lilly, and JPMorgan’s contrasting stock performances.

Broadcom Inc. (AVGO), headquartered in Palo Alto, California, is currently facing mixed performance metrics compared to major market indices. On the latest trading session, Broadcom saw its stock close at $199.45, marking a +0.84% move from the previous day. While any gain is welcome, this still trails the S&P 500's daily gain of 1.59%, the Dow's increase of 1.39%, and the Nasdaq's rise by 1.63%. Over the last month, shares of Broadcom have lost 8.28%, which raises concerns especially as the Computer and Technology sector lost 3.43% and the S&P 500 only saw a 2.42% decline.

Looking forward, Broadcom's upcoming earnings release is set for March 6, 2025, where analysts predict the company will report earnings per share (EPS) of $1.50—a 36.36% growth from last year's equivalent quarter. The expected revenue of $14.62 billion also shows promise, indicating a 22.23% increase from the same quarter last year. The Zacks Consensus Estimates for the annual period project earnings of $6.31 per share and revenue of $61 billion, marking shifts of +29.57% and +18.28%, respectively, from last year. According to Zacks, “Broadcom Inc. possesses a Zacks Rank of #2 (Buy),” indicating favorable opinions on its future prospects.

Broadcom maintains its status as one of the mega-cap stocks, with their continued dominance notable particularly through their investments related to 5G and AI innovations. Despite recent struggles, particularly with AVGO's stock slipping 21.5% from its 52-week high, the company's stock has gained 23.9% over the last three months, significantly outperforming the Dow Jones Industrial Average's loss of 3.3%. Long-term, shares of Broadcom have climbed 52.6% over the past 52 weeks.

Switching gears, the Coca-Cola Company (KO), which specializes in non-alcoholic beverages from its Atlanta, Georgia headquarters, is also showing impressive growth metrics. The company is renowned for its market cap of $304.5 billion and its extensive brand portfolio, which includes Coca-Cola, Sprite, and Fanta. KO stock is currently trading 3.6% below its 52-week high of $73.53 but has seen significant movements, gaining 10% over the past three months, significantly outperforming the broader S&P 500 index’s decline.

During the first quarter this year, Coca-Cola reported revenue growth of 5.4% to $11.54 billion, surpassing estimates by 7.8%. Adjusted EPS was reported at $0.55, beating projections by 6.4%. Analysts remain optimistic about Coca-Cola’s future, with the stock receiving strong buy ratings from 22 analysts along with potential upside suggested by mean price targets exceeding current levels.

Eli Lilly and Company (LLY), based out of Indianapolis, Indiana, is leading the healthcare space with its remarkable performance driven by blockbuster products. LLY has gained 14.8% over the past three months and rose 17.3% year-to-date. Despite recent fluctuations, including a slip of 6.9% from its 52-week high of $972.53, the company’s stock continues to trade above its 50-day and 200-day moving averages, indicating overall bullish sentiment.

Recent earnings highlighted the breadth of its product offerings. Eli Lilly's revenue of $13.5 billion reported during its last earnings call slightly missed analysts' expectations. Nonetheless, the company’s strong outlook is bolstered by its consensus ‘Strong Buy’ ratings from 24 analysts, with price targets indicating substantial upside potential from current trading levels.

Finally, JPMorgan Chase & Co. (JPM), another mega-cap company with total market value at $723.6 billion, is solidifying its place as a financial leader. Over the past year, JPM's stock gained 41.2%, outperforming both its sector peers and market indices. Despite currently trading 7.6% below its 52-week high of $280.25, it has still posted increases, including 3.7% growth over the last three months.

Recent earnings reports exceeded expectations, with JPM reporting earnings per share of $4.81 and total managed revenue of $43.7 billion, reflecting financial strength against operating margin challenges. The stock has earned moderate buy ratings from analysts which suggest continued investment potential.

This comparative analysis of Broadcom, Coca-Cola, Eli Lilly, and JPMorgan provides valuable insight on their performances relative to market indices, enabling investors to gauge their positions within the current economic climate. With mega-cap stocks demonstrating resilience and potential for growth, they remain areas of interest for future investments.